• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CASHEL 466FXXXX; FILTER, INTRAVASCULAR, CARDIOVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CASHEL 466FXXXX; FILTER, INTRAVASCULAR, CARDIOVASCULAR Back to Search Results
Catalog Number 466FXXXX
Device Problem Therapy Delivered to Incorrect Body Area (1508)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/01/2011
Event Type  malfunction  
Manufacturer Narrative
Kalva, s.P., marentis, t.C., yeddula, k., somarouthu, b., wicky, s., & stecker, m.S.(2010).Long-term safety and effectiveness of the ¿optease¿ vena cava filter. cardiovascular and interventional radiology, 34(2), 331-337.Doi:10.1007/s00270-010-9969-9 this article was found during a recent clinical evaluation review/literature search of this device.Please note that patient specific details (demographics, medical history and reason for intervention) are not available.  the devices are optease vena cava filters but the catalog and lot numbers are not available.  as noted in the publication by kalva et al long-term safety and effectiveness of the "optease" vena cava filter, cardiovasc intervent radiol (2011) 34(2): 331-337; in one patient, the filter was malpositioned (filter placed upside down), and subsequent attempts to retrieve the filter were unsuccessful.A non-cordis filter was then placed above the malpositioned optease filter in a suprarenal location.There were no other complications during placement.The product was not returned for analysis.Additionally, as the sterile lot number was not available, device history record review could not be performed.  the optease vena cava filter is indicated for use in the prevention of recurrent pulmonary embolism (pe) via percutaneous placement in the vena cava for patients in which anticoagulants are contraindicated, anticoagulant therapy for thromboembolic disease has failed, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced or for chronic, recurrent pulmonary embolism where anticoagulant therapy has failed, or is contraindicated.Incorrect orientation of the filter is a known potential complication for all ivc filter implants and is listed in the instructions for use (ifu) as such.Per ifu, the optease must be implanted with the fixation barbs to the cranial end and retrieval hook to the caudal end of the filter.Patient, technique or procedural factors during the implantation and attempted retrieval may have contributed to the reported event.Given the limited information available for review at this time, there is nothing to suggest that the reported event is related to the design and manufacturing process of the device; therefore no corrective action will be taken.Should additional information become available, the file will be updated accordingly.
 
Event Description
As noted in the publication by kalva et al long-term safety and effectiveness of the "optease" vena cava filter, cardiovasc intervent radiol (2011) 34(2): 331-337; in one patient, the filter was malpositioned (filter placed upside down), and subsequent attempts to retrieve the filter were unsuccessful.A non-cordis filter was then placed above the malpositioned optease filter in a suprarenal location.There were no other complications during placement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
466FXXXX
Type of Device
FILTER, INTRAVASCULAR, CARDIOVASCULAR
Manufacturer (Section D)
CORDIS CASHEL
cahir road
cashel, co. tipperary
EI 
Manufacturer (Section G)
CORDIS CASHEL
cahir road
cashel, co. tipperary
EI  
Manufacturer Contact
karla castro
14201 nw 60th ave
miami lakes, FL 33014
MDR Report Key6676737
MDR Text Key78713432
Report Number1016427-2017-00414
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K034050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Health Professional
Type of Report Initial
Report Date 06/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/29/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number466FXXXX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date06/06/2017
Date Manufacturer Received06/06/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
COOK TULIP FILTER
-
-